Ausgabe 2/1997
Inhalt (9 Artikel)
The tumor-bearing state induces augmented responses of organ-associated lymphocytes to high-dose interleukin-2 therapy in mice
Y. Asano, K. Kaneda, J. Hiragushi, T. Tsuchida, K. Higashino
Restoration of macrophage tumoricidal activity by bleomycin correlates with the decreased production of transforming growth factor β in rats bearing KDH-8 hepatoma cells
L. Yuan, Masanobu Kobayashi, Yasuhiro Kuramitsu, Yongging Li, Kazushiro Matsushita, M. Hosokawa
Sequence variation in the monoclonal-antibody-U36-defined CD44v6 epitope
Nicole L. W. Van Hal, G. A. M. S. Van Dongen, C. B. M. Ten Brink, Jim N. Herron, Gordon B. Snow, R. H. Brakenhoff
Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2
C. A. Kruse, Linda Cepeda, Betty Owens, Stephen D. Johnson, John Stears, Kevin O. Lillehei
Antitumor effects of the combination immunotherapy with interleukin-12 and tumor necrosis factor α in mice
W. Lasek, Wojciech Feleszko, Jakub Goląb, Tomasz Stokłosa, Maria Marczak, Anna Dąbrowska, Magdalena Malejczyk, Marek Jakóbisiak
Intrapleural instillation of interferon γ in patients with malignant pleurisy due to lung cancer
H. Yanagawa, Takashi Haku, Keiji Hiramatsu, Hiroshi Nokihara, Eiji Takeuchi, Seiji Yano, Masaki Hanibuchi, Saburo Sone
The antitumor effects of levamisole in mice are mediated by NC-1.1+ cells
Gregory R. Clarke, Robert C. Burton, Y. Cheng Smart
Active and indolent chronic lymphocytic leukaemia – immune and hormonal peculiarities
H. Everaus, E. Luik, Jane Lehtmaa
Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: evaluation of efficacy and tolerability
Filiberto Belli, Flavio Arienti, J. Sulé-Suso, C. Clemente, Luigi Mascheroni, Alessandro Cattelan, Cristina Santantonio, Gian Francesco Gallino, Cecilia Melani, Stefania Rao, Mario P. Colombo, Michele Maio, Natale Cascinelli, G. Parmiani